↓ Skip to main content
What is this page? Embed badge

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
2 policy sources
twitter
8 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
115 Mendeley
Summary Policy documents Twitter Facebook Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd009256.pub2
Pubmed ID
23949842
Authors

Tiago B de Castria, Edina MK da Silva, Aecio FT Gois, Rachel Riera

Abstract

An estimated 220,000 new cases of non-small cell lung cancer (NSCLC) and 160,000 deaths are expected to occur in the US in 2013, representing about 28% of cancer-related mortality. Approximately 75% of these people will have locally advanced or metastatic disease and will be treated in a palliative setting. Platinum-based combination chemotherapy has benefits in terms of survival and symptom control when compared with best supportive care.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Unknown 113 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 17%
Student > Ph. D. Student 17 15%
Researcher 13 11%
Student > Bachelor 11 10%
Other 11 10%
Other 22 19%
Unknown 21 18%
Readers by discipline Count As %
Medicine and Dentistry 53 46%
Nursing and Health Professions 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Economics, Econometrics and Finance 3 3%
Other 13 11%
Unknown 25 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2022.
All research outputs
#2,787,672
of 22,716,996 outputs
Outputs from Cochrane database of systematic reviews
#5,464
of 12,314 outputs
Outputs of similar age
#22,590
of 175,522 outputs
Outputs of similar age from Cochrane database of systematic reviews
#106
of 225 outputs
Altmetric has tracked 22,716,996 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.

This page is provided by Altmetric.